Association of bone turnover markers with mortality in men referred to coronary angiography

Osteoporosis International

Volumn 24, Issue 4, 2013, Pages 1321-1332

  Lerchbaum, E ^a   Schwetz, V ^a   Pilz, S ^a,b   Grammer, T B ^c   Look, M ^d   Boehm, B O ^e   Obermayer Pietsch, B ^a   Marz W ^a,c,d  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d SYNLAB ACADEMY   (Germany)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

Beta crosslaps; Bone turnover; Cardiovascular disease; Mortality; Osteocalcin

Indexed keywords

BETA CROSSLAPS; BIOLOGICAL MARKER; MEMBRANE PROTEIN; OSTEOCALCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BONE TURNOVER; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORTALITY; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; BIOLOGICAL MARKERS; BONE REMODELING; CARDIOVASCULAR DISEASES; COLLAGEN; CORONARY ANGIOGRAPHY; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; MORTALITY; OSTEOCALCIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84876484234     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-012-2076-9     Document Type: Article

References (37)

1. Sambrook PN, Chen CJ, March L, Cameron ID, Cumming RG, Lord SR, Simpson JM, Seibel MJ (2006) High bone turnover is an independent predictor of mortality in the frail elderly. J Bone Miner Res 21(4):549-555
2. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ 3rd (1993) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137(9):1001-1005
3. Trivedi DP, Khaw KT (2001) Bone mineral density at the hip predicts mortality in elderly men. Osteoporos Int 12(4):259-265
4. Reyes-Garcia R, Rozas-Moreno P, Jimenez-Moleon JJ, Villoslada MJ, Garcia-Salcedo JA, Santana-Morales S, Muñoz-Torres M (2011) Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes. Diabetes Metab in press
5. Vogt MT, San Valentin R, Forrest KY, Nevitt MC, Cauley JA (1997) Bone mineral density and aortic calcification: the Study of Osteoporotic Fractures. J Am Geriatr Soc 45(2):140-145
6. Watson KE, Boström K, Ravindranath R, Lam T, Norton B, Demer LL (1994) TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93(5):2106-2113
7. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ (2001) Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21(12):1998-2003
8. Im JA, Yu BP, Jeon JY, Kim SH (2008) Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chem Acta 396(1-2):66-69
9. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B (2009) Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 94(3):827-832
10. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, Sugimoto T (2009) Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 94(1):45-49
11. Yeap BB, Chubb SA, Flicker L, McCaul KA, Ebeling PR, Hankey GJ, Beilby JP, Norman PE (2012) Associations of total osteocalcin with all-cause and cardiovascular mortality in older men. The Health In Men Study. Osteoporos Int 23(2):599-606
12. Peichl P, Griesmacherb A, Marteau R, Hejc S, Kumpan W, Müller MM, Bröll H (2001) Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers. Clin Biochem 34(2):131-139
13. Winkelmann BR, März W, Boehm BO, Zotz R, Hager J, Hellstern P, Senges J, LURIC Study Group (LUdwigshafen RIsk and Cardiovascular Health) (2001) Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2(1 Suppl 1):S1-S73
14. National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) (2002) National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 106(25):3143-3421
15. Hamann C, Kirschner S, Günther KP, Hofbauer LC (2012) Bone, sweet bone-osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 8(5):297-305
16. Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119(21):2765-2771
17. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130(3):456-469
18. Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, Hermo L, Suarez S, Roth BL, Ducy P, Karsenty G (2011) Endocrine regulation of male fertility by the skeleton. Cell 144(5):796-809
19. Kirmani S, Atkinson EJ, Melton LJ 3rd, Riggs BL, Amin S, Khosla S (2011) Relationship of testosterone and osteocalcin levels during growth. J Bone Miner Res 26(9):2212-2216
20. Wehr E, Pilz S, Boehm BO, März W, Grammer TB, Obermayer-Pietsch B (2010) Sex steroids and mortality in men referred for coronary angiography. Clin Endocrinol 73(5):613-621
21. Wehr E, Pilz S, Boehm BO, März W, Grammer T, Obermayer-Pietsch B (2011) Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography. Eur J Heart Fail 13(5):482-488
22. Pal SN, Rush C, Parr A, Van Campenhout A, Golledge J (2010) Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. Atherosclerosis 210(1):88-93
23. Montalcini T, Emanuele V, Ceravolo R, Gorgone G, Sesti G, Perticone F, Pujia A (2004) Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women. Am J Cardiol 94(2):266-269
24. Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T, Fiore CE (2004) Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 15(5):389-395
25. Meier C, Nguyen TV, Center JR, Seibel MJ, Eisman JA (2005) Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study. J Bone Miner Res 20(4):579-587
26. Szulc P, Garnero P, Claustrat B, Marchand F, Duboeuf F, Delmas PD (2002) Increased bone resorption in moderate smokers with low body weight: the Minos study. J Clin Endocrinol Metab 87(2):666-674
27. Szulc P, Samelson EJ, Kiel DP, Delmas PD (2009) Increased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study. J Bone Miner Res 24(12):2023-2031
28. Sambrook PN, Chen JS, March LM, Cameron ID, Cumming RG, Lord SR, Schwarz J, Seibel MJ (2004) Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 89(11):5477-5481
29. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266-281
30. Lerchbaum E, Pilz S, Grammer TB, Boehm BO, März W, Obermayer-Pietsch B (2011) High estradiol levels are associated with increased mortality in older men referred to coronary angiography. Exp Clin Endocrinol Diabetes 119(8):490-496
31. Røysland R, Bonaca MP, Omland T, Sabatine M, Murphy SA, Scirica BM, Bjerre M, Flyvbjerg A, Braunwald E, Morrow DA (2012) Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. Heart 98(10):786-791
32. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G (2010) Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142(2):296-308
33. Ferron M, Hinoi E, Karsenty G, Ducy P (2008) Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105(13):5266-5270
34. Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, Sugimoto T (2011) Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 22(1):187-194
35. Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, Jacques PF, Booth SL (2009) Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 90(5):1230-1235
36. Gundberg CM (2009) Vitamin K and bone: past, present, and future. J Bone Miner Res 24(6):980-982
37. Schafer AL, Sellmeyer DE, Schwartz AV, Rosen CJ, Vittinghoff E, Palermo L, Bilezikian JP, Shoback DM, Black DM (2011) Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab 96(12):E1982-E1989